Belgium Approves Extension Trial of Abivax’s Ulcerative Colitis Therapy
News
Regulators in Belgium have approved Abivax’s request for a long-term extension of the company’s ongoing Phase 2a trial of ABX464 as a treatment for ulcerative colitis. It said it expects approvals from ... Read more